SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-002666
Filing Date
2022-03-02
Accepted
2022-03-02 16:08:39
Documents
105
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K icpt-20211231x10k.htm   iXBRL 10-K 3283002
2 EX-4.11 icpt-20211231xex4d11.htm EX-4.11 26984
3 EX-21.1 icpt-20211231xex21d1.htm EX-21.1 12538
4 EX-23.1 icpt-20211231xex23d1.htm EX-23.1 2495
5 EX-31.1 icpt-20211231xex31d1.htm EX-31.1 11830
6 EX-31.2 icpt-20211231xex31d2.htm EX-31.2 11718
7 EX-32 icpt-20211231xex32.htm EX-32 9744
8 GRAPHIC icpt-20211231x10k008.jpg GRAPHIC 44106
  Complete submission text file 0001558370-22-002666.txt   12236091

Data Files

Seq Description Document Type Size
9 EX-101.SCH icpt-20211231.xsd EX-101.SCH 72390
10 EX-101.CAL icpt-20211231_cal.xml EX-101.CAL 84254
11 EX-101.DEF icpt-20211231_def.xml EX-101.DEF 310083
12 EX-101.LAB icpt-20211231_lab.xml EX-101.LAB 557812
13 EX-101.PRE icpt-20211231_pre.xml EX-101.PRE 530387
99 EXTRACTED XBRL INSTANCE DOCUMENT icpt-20211231x10k_htm.xml XML 2254481
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35668 | Film No.: 22703492
SIC: 2834 Pharmaceutical Preparations